Google Alert - hepatitis c

[Guest guest]

News

9 new results for hepatitis c

Hepatitis C outbreak: nursing director chargedThe AgeShe is the first person to be charged over the string of hepatitis C infections, and will appear at Melbourne Magistrates Court tomorrow. ...See all stories on this topic »

Roche dumps hep C development deal with LigandFierceBiotechThis time the Swiss pharma giant is dropping a deal to develop new hepatitis C drugs with Ligand Pharmaceuticals ($LGNDD), according to the UK biotech. ...See all stories on this topic »

HRSA Grants $1.6 Million for Hepatitis C Treatment InitiativeADVANCE (blog)19, the Health Resources and Services Administration (HRSA) announced that it has awarded $1.6 million in grants to support the Hepatitis C Treatment ...See all stories on this topic »

Idenix rises after HIV drug milestone paymentBusinessWeekBut Idenix is still trying to determine the fate of two other drug candidates, IDX184 and IDX320, which treat hepatitis C. The Food and Drug Administration ...See all stories on this topic »

Ex-model challenges infected blood damages schemeSunderland EchoA former model from Bedfordshire infected with hepatitis C after being given a blood transfusion more than 20 years ago is challenging the legality of the ...See all stories on this topic »

Small Biotech's Roche Deal is KaputMinyanville.comAt least that's how Ligand Pharmaceuticals (LGNDD) is telling investors that Roche is exiting their partnership to develop a Hepatitis C treatment. ...See all stories on this topic »

Roche terminates HCV deal with MetabasisPharmaceutical Business ReviewRoche has issued a notice to Ligand Pharmaceutical declaring its termination of collaboration and licensing agreement on developing hepatitis C treatment ...See all stories on this topic »

Pharmasset Reports Fiscal Year End 2010 Financial ResultsBradenton HeraldFour hundred and eight treatment-naïve, genotypes 1 or 4 hepatitis C virus (HCV)-infected patients (cirrhotic and non-cirrhotic) were enrolled. ...See all stories on this topic »

New Lows of NASDAQ (ANDS, CTE, SBRA, SGMS, GIGM)TechRockz(NASDAQ:ANDS) Anadys Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing medicines in the areas of hepatitis C ,currently is trading ...See all stories on this topic »